The IBSA Group was founded in 1945 and is today the largest privately owned pharmaceutical company in Switzerland, present in 5 continents and over 80 countries with a product portfolio covering 9 major therapeutic areas. One of IBSA’s fastest growing areas is dermoaesthetics, offering a full range of products such as Viscoderm®, Aliaxin® and Profhilo® based on Hydrolift® Action. Hydrolift® Action is an innovative approach aimed at counteracting the physiological reduction of hyaluronic acid in the skin, restoring hydration, elasticity and skin tone. Hydrolift® Action is an expression of the synergistic action derived from the use of selected hyaluronic acid produced using IBSA technology, which when used in combination create optimal conditions for preventing and fighting the aging process.